Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine

Ebolaviruses Zaire (EBOV), Bundibugyo (BDBV), and Sudan (SUDV) cause human disease with high case fatality rates. Experimental monovalent vaccines, which all utilize the sole envelope glycoprotein (GP), do not protect against heterologous ebolaviruses. Human parainfluenza virus type 3-vectored vacci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Kimble, J. Brian, Malherbe, Delphine C., Meyer, Michelle, Gunn, Bronwyn M., Karim, Marcus M., Ilinykh, Philipp A., Iampietro, Mathieu, Mohamed, Khaled S., Negi, Surendra, Gilchuk, Pavlo, Huang, Kai, Wolf, Yuri I., Braun, Werner, Crowe, James E., Alter, Galit, Bukreyev, Alexander
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364037/
https://ncbi.nlm.nih.gov/pubmed/30518655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01845-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados